Acne & Hidradenitis Suppurativa
Acne and hidradenitis suppurativa (HS) are common inflammatory skin disorders affecting adolescents and occasionally younger children. Both disorders are associated with challenging physical symptoms, profound psychosocial burden, and can lead to permanent scarring. Recent scientific advances have improved our understanding of these inflammatory skin diseases and led to efficacious, FDA-approved treatment options. However, not all treatments are approved in children and questions remain surrounding long-term effects of diseases and treatments.
The goals of the Acne & HS Focused Study Group are to define and address unmet research needs in these disorders and to advance our understanding of biomarkers, genetic influences, and disease co-morbidities, in order to best treat our pediatric and adolescent patients.
The Acne & HS Focused Study Group is chaired by Andrea Zaenglein, MD at Penn State Health, and co-chaired by Leah Lalor, MD at the Medical College of Wisconsin and Irene Lara-Corrales, MD at the University of Toronto.
Studies Seeking Collaborators
Acne Uniform Data Collection
Isotretinoin use in African American and Hispanic Youth
Acne in Transgender Youth
Moderate to Severe HS in Children and Adolescents
Acne Medication Coverage in Medicaid Formularies
Zaenglein, Andrea, et al. “Executive Summary: Consensus Recommendations for the Use of Retinoids in Ichthyosis and Other Disorders of Cornification in Children and Adolescents” Journal of the American Academy of Dermatology (2021).
Liy-Wong, Carmen, et al. “Hidradenitis Suppurativa in the Pediatric Population: An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients” JAMA Dermatology (2021).
Active Member Locations
Send us an email to get connected to the Acne & HS group or to learn more.